Literature DB >> 11948774

Hardware-related problems of deep brain stimulation.

Carole Joint1, Dipankar Nandi, Simon Parkin, Ralph Gregory, Tipu Aziz.   

Abstract

Deep brain stimulation for the alleviation of movement disorders and pain is now an established therapy. However, very little has been published on the topic of hardware failure in the treatment of such conditions irrespective of clinical outcome. Such device-related problems lead to significant patient morbidity and increased cost of therapy in the form of prolonged antibiotics, in-patient hospitalization, repeat surgery, and device replacement. We report a prospective review of our experience at the Radcliffe Infirmary Oxford from the period of April 1998 to March 2001. Overall there is a 20% rate of hardware-related problems in this series, which falls between the 7% and 65% rates reported by other groups. The majority of these failures occurred early on in the series, and numbers declined with experience. Some of the problems may be idiosyncratic to the methodology of individual groups. Copyright 2002 Movement Disorder Society

Entities:  

Mesh:

Year:  2002        PMID: 11948774     DOI: 10.1002/mds.10161

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  22 in total

Review 1.  High frequency deep brain stimulation of the subthalamic nucleus versus continuous subcutaneous apomorphine infusion therapy: a review.

Authors:  R Carron; V Fraix; C Maineri; E Seigneuret; B Piallat; P Krack; P Pollak; A L Benabid; Stéphan Chabardès
Journal:  J Neural Transm (Vienna)       Date:  2010-12-29       Impact factor: 3.575

2.  Impact of advancing age on post-operative complications of deep brain stimulation surgery for essential tremor.

Authors:  Terence Verla; Andrew Marky; Harrison Farber; Frank W Petraglia; John Gallis; Yuliya Lokhnygina; Beth Parente; Patrick Hickey; Dennis A Turner; Shivanand P Lad
Journal:  J Clin Neurosci       Date:  2015-02-07       Impact factor: 1.961

3.  Operative techniques and morbidity with subthalamic nucleus deep brain stimulation in 100 consecutive patients with advanced Parkinson's disease.

Authors:  R R Goodman; B Kim; S McClelland; P B Senatus; L M Winfield; S L Pullman; Q Yu; B Ford; G M McKhann
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-01       Impact factor: 10.154

Review 4.  Deep Brain Stimulation Emergencies: How the New Technologies Could Modify the Current Scenario.

Authors:  Giovanni Cossu; Mariachiara Sensi
Journal:  Curr Neurol Neurosci Rep       Date:  2017-07       Impact factor: 5.081

Review 5.  Neuropathic pain and deep brain stimulation.

Authors:  Erlick A C Pereira; Tipu Z Aziz
Journal:  Neurotherapeutics       Date:  2014-07       Impact factor: 7.620

6.  [Abscess at the implant site following apical parodontitis. Hardware-related complications of deep brain stimulation].

Authors:  F Sixel-Döring; C Trenkwalder; C Kappus; D Hellwig
Journal:  Nervenarzt       Date:  2006-08       Impact factor: 1.214

7.  Lead Fractures in Deep Brain Stimulation during Long-Term Follow-Up.

Authors:  Fernando Seijo Fernández; Marco Antonio Alvarez Vega; Aida Antuña Ramos; Fernando Fernández González; Beatriz Lozano Aragoneses
Journal:  Parkinsons Dis       Date:  2009-12-13

8.  Delayed cerebritis after bilateral stereotactic implantation of globus pallidus interna electrodes for treatment of dystonia.

Authors:  Pawel P Jankowski; Stephanie Lessig; Andrew D Nguyen; David Barba
Journal:  BMJ Case Rep       Date:  2013-02-01

Review 9.  Identification and management of deep brain stimulation intra- and postoperative urgencies and emergencies.

Authors:  Takashi Morishita; Kelly D Foote; Adam P Burdick; Yoichi Katayama; Takamitsu Yamamoto; Steven J Frucht; Michael S Okun
Journal:  Parkinsonism Relat Disord       Date:  2009-11-05       Impact factor: 4.891

10.  Management of skin erosion following deep brain stimulation.

Authors:  Michele Lanotte; Giovanni Verna; Pier Paolo Panciani; Antonio Taveggia; Maurizio Zibetti; Leonardo Lopiano; Alessandro Ducati
Journal:  Neurosurg Rev       Date:  2008-09-05       Impact factor: 3.042

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.